MAY 24, 2017 12:00 PM PDT

Adaptive Process Design, Automation & Analytics in Laboratory R&D

Presented at: Lab Automation 2017
Speaker
  • Founder/CEO, Riffyn
    Biography
      Tim Gardner is the Founder and the CEO of Riffyn. He also serves as an advisor to the European Union Scientific Committees and the Boston University Engineering Alumni Advisory Board. He was previously Vice President of Research & Development at Amyris, where he led the engineering of yeast strain and processes technology for large-scale (1.2 million liter) bio-manufacturing of renewable chemicals. He was also an Assistant Professor of Biomedical Engineering at Boston University, the Founder of Cellicon Biotechnologies, and a Programmer at ALK Associates. Tim has been recognized for his pioneering work in Synthetic Biology by Scientific American, the New Scientist, Nature, Technology Review, and the New York Times. He holds BS in Mechanical Engineering from Princeton University and a PhD in Biomedical Engineering from Boston University. Tim enjoys hockey, running, mountain biking, and being beaten by his 6 and 8 year-old sons in almost everything.

    Abstract

    R&D in life science, material science, and chemistry is burdened by fragmented and unstructured data (“spreadsheet hell”), and ambiguous or unrecorded methodological data. This leads to low-confidence decisions, wasteful rework, missed observations, and delayed or failed technology transfer across sites or scales of development.

    “Data science” and “big data” tools are often hailed as a solution to these problems.  But statisticians and data scientists spend more time gathering, cleaning, and linking data than actually learning from it. The ability to “clean-up” data is impaired by the dynamic nature of R&D processes, the heterogeneity of data sources, and the complexity of modern R&D organizations.

    Riffyn’s cloud-based software platform uses visual process design and integrated data analytics to solve these problems. Riffyn collects data from people, instruments and databases, and uses the process design to contextualize the data the moment it is generated. It then uses the process design to automatically summarize and join all that data into standard tables for rich statistical analysis, visualization and machine learning — allowing users to instantly answer questions of cause-and-effect across traditional silos of team, place and discipline.  Thus by simply creating a process and experiment design with Riffyn, scientists and engineers have effectively architected their own vertically-integrated data system (front end, database, & ETL) in less time than it would have taken to communicate their data requirements to IT.

    With built-in versioning, Riffyn is also continuously adapting — so that laboratory methods, data and, analysis are always in sync with ever-changing R&D processes.  This frees each organization’s IT team to attack the backlog of high-value analytical and business intelligence projects that are usually sidelined by the heavy burden of core system maintenance. No longer will database development or data integration be a drain of precious IT resources, nor a bottleneck to scientists and engineers who are trying to improve their R&D processes.

    The result is a new level of transparency and confidence in R&D decisions, a culture of continuous improvement, and corresponding gains in R&D effectiveness.

     


    Show Resources
    You May Also Like
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    MAY 11, 2021 10:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    APR 01, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 01, 2021 8:00 AM PDT
    Date: April 01, 2021 Time: 8:00am (PST), 11:00am (EST) Generating therapeutic antibodies is far more challenging than obtaining antibodies that merely recognize their targets. Engineering po...
    APR 19, 2021 8:00 AM PDT
    C.E. CREDITS
    APR 19, 2021 8:00 AM PDT
    Date: Apri 19, 2021 Time: 8:00am PDT, 5:00pm CEST Since the inception of modern biological research, BioSafety has evolved into a critical consideration in Good Laboratory Practices (GLP). Wi...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    MAY 24, 2017 12:00 PM PDT

    Adaptive Process Design, Automation & Analytics in Laboratory R&D

    Presented at: Lab Automation 2017

    No demographic data is available yet for this event.


    Show Resources
    Loading Comments...
    Show Resources